vs
Side-by-side financial comparison of ARGENX SE (ARGX) and Dole plc (DOLE). Click either name above to swap in a different company.
ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $2.3B, roughly 1.1× Dole plc). ARGENX SE runs the higher net margin — 35.5% vs 0.2%, a 35.2% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs 10.5%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $66.5M).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Dole plc is an Irish-American agricultural multinational corporation headquartered in Dublin, Ireland. The company is among the world's largest producers of fruit and vegetables, operating with 38,500 full-time and seasonal employees who supply some 300 products in 75 countries. Dole reported 2021 revenues of $6.5 billion.
ARGX vs DOLE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $2.3B |
| Net Profit | $877.2M | $5.1M |
| Gross Margin | 89.5% | 6.8% |
| Operating Margin | 28.9% | 1.1% |
| Net Margin | 35.5% | 0.2% |
| Revenue YoY | 83.2% | 10.5% |
| Net Profit YoY | 1.3% | -64.6% |
| EPS (diluted) | $13.25 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5B | — | ||
| Q3 25 | — | $2.3B | ||
| Q2 25 | $1.8B | $2.4B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | $901.9M | $2.1B | ||
| Q1 24 | — | $2.1B |
| Q4 25 | $877.2M | — | ||
| Q3 25 | — | $5.1M | ||
| Q2 25 | $414.8M | $10.0M | ||
| Q1 25 | — | $38.9M | ||
| Q4 24 | $865.6M | — | ||
| Q3 24 | — | $14.4M | ||
| Q2 24 | $-32.5M | $80.1M | ||
| Q1 24 | — | $70.1M |
| Q4 25 | 89.5% | — | ||
| Q3 25 | — | 6.8% | ||
| Q2 25 | 89.2% | 9.0% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | 90.2% | — | ||
| Q3 24 | — | 8.0% | ||
| Q2 24 | 89.4% | 9.4% | ||
| Q1 24 | — | 9.2% |
| Q4 25 | 28.9% | — | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | 19.2% | 4.3% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | -15.4% | 4.0% | ||
| Q1 24 | — | 5.3% |
| Q4 25 | 35.5% | — | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | 23.4% | 0.4% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | 64.1% | — | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | -3.6% | 3.8% | ||
| Q1 24 | — | 3.3% |
| Q4 25 | $13.25 | — | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | $6.32 | $0.10 | ||
| Q1 25 | — | $0.41 | ||
| Q4 24 | $13.33 | — | ||
| Q3 24 | — | $0.15 | ||
| Q2 24 | $-0.55 | $0.84 | ||
| Q1 24 | — | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $321.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.3B | $1.4B |
| Total Assets | $8.7B | $4.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.5B | — | ||
| Q3 25 | — | $321.0M | ||
| Q2 25 | $2.1B | $323.1M | ||
| Q1 25 | — | $261.0M | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | — | $266.4M | ||
| Q2 24 | $1.4B | $225.8M | ||
| Q1 24 | — | $245.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $11.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | $7.3B | — | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | $6.1B | $1.4B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $5.5B | — | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $4.3B | $1.4B | ||
| Q1 24 | — | $1.3B |
| Q4 25 | $8.7B | — | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | $7.2B | $4.7B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | $6.2B | — | ||
| Q3 24 | — | $4.5B | ||
| Q2 24 | $4.8B | $4.4B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | $87.4M |
| Free Cash FlowOCF − Capex | $322.4M | $66.5M |
| FCF MarginFCF / Revenue | 13.0% | 2.9% |
| Capex IntensityCapex / Revenue | 0.0% | 0.9% |
| Cash ConversionOCF / Net Profit | 0.37× | 17.12× |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | $13.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $323.3M | — | ||
| Q3 25 | — | $87.4M | ||
| Q2 25 | $361.8M | $18.3M | ||
| Q1 25 | — | $-78.8M | ||
| Q4 24 | $41.9M | — | ||
| Q3 24 | — | $101.0M | ||
| Q2 24 | $-124.7M | $40.2M | ||
| Q1 24 | — | $-35.0M |
| Q4 25 | $322.4M | — | ||
| Q3 25 | — | $66.5M | ||
| Q2 25 | $356.6M | $-1.0M | ||
| Q1 25 | — | $-131.6M | ||
| Q4 24 | $40.9M | — | ||
| Q3 24 | — | $79.9M | ||
| Q2 24 | $-125.5M | $22.8M | ||
| Q1 24 | — | $-53.2M |
| Q4 25 | 13.0% | — | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | 20.1% | -0.0% | ||
| Q1 25 | — | -6.3% | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | — | 3.9% | ||
| Q2 24 | -13.9% | 1.1% | ||
| Q1 24 | — | -2.5% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | 0.3% | 0.8% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | 0.1% | 0.8% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | 17.12× | ||
| Q2 25 | 0.87× | 1.84× | ||
| Q1 25 | — | -2.02× | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | 7.01× | ||
| Q2 24 | — | 0.50× | ||
| Q1 24 | — | -0.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
